Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

49.34 +0.50 (+1.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 424,836
Open 48.93
Bid (Size) 47.00 (1)
Ask (Size) 51.42 (1)
Prev. Close 48.84
Today's Range 48.16 - 50.42
52wk Range 33.04 - 62.09
Shares Outstanding 59,317,554
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Healthcare Stocks That Will Be Big Winners in 2023
Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider. 
Via InvestorPlace
If You Invested $1,000 in Novavax In 2020, This Is How Much You Would Have Today
The stock has gone on a wild ride over the past few years. 
Via The Motley Fool

Performance

YTD
-6.84%
-6.84%
1 Month
-8.49%
-8.49%
3 Month
-13.61%
-13.61%
6 Month
-8.63%
-8.63%
1 Year
+29.47%
+29.47%

More News

Read More
With This Big Transition Ahead, Is Novavax a Buy?
Via The Motley Fool
2 Biotechs Making Waves With A Single Product in their Pipeline
Via MarketBeat
NVAX Stock Alert: What to Know as Novavax Names New CEO
Via InvestorPlace
4 Analysts Have This to Say About Harmony Biosciences
Via Benzinga
Where Harmony Biosciences Stands With Analysts
Via Benzinga
6 Analysts Have This to Say About Harmony Biosciences
Via Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Moderna Stock Shows Surprising Strength; Key Rating Upgraded
Via Investor's Business Daily
BeiGene Stock Shows Market Leadership With Jump To 82 RS Rating
Via Investor's Business Daily
Xenon Pharmaceuticals Stock Scores Rising Relative Strength Upgrade
Via Investor's Business Daily
BioCryst Pharmaceuticals Stock Sees RS Rating Rise To 84
Via Investor's Business Daily
Looking Into Harmony Biosciences's Return On Capital Employed
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript
Via The Motley Fool
Why IBD 50 Stock Harmony Biosciences Flew To The High End Of Its Buy Zone
Via Investor's Business Daily
Recap: Harmony Biosciences Q3 Earnings
Via Benzinga
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
From Harmony Biosciences
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
Via Benzinga
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday
Via Benzinga
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
Via Benzinga
Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.